Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23576573)

1.

SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJ.

Brenca M, Rossi S, Lorenzetto E, Piccinin E, Piccinin S, Rossi FM, Giuliano A, Dei Tos AP, Maestro R, Modena P.

Mol Cancer Ther. 2013 Jun;12(6):1060-72. doi: 10.1158/1535-7163.MCT-13-0005. Epub 2013 Apr 10.

2.

Epithelioid sarcoma on the face in an elderly patient.

[No authors listed]

J Craniofac Surg. 2015 May;26(3):956-8. doi: 10.1097/SCS.0000000000001433. No abstract available.

PMID:
25950524
3.

Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.

Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT.

J Cutan Pathol. 2015 May;42(5):308-17. doi: 10.1111/cup.12481. Epub 2015 Mar 24.

PMID:
25754356
4.

SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.

Folpe AL, Schoolmeester JK, McCluggage WG, Sullivan LM, Castagna K, Ahrens WA, Oliva E, Biegel JA, Nielsen GP.

Am J Surg Pathol. 2015 Jun;39(6):836-49. doi: 10.1097/PAS.0000000000000397.

PMID:
25651469
5.

ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.

Kohashi K, Yamada Y, Hotokebuchi Y, Yamamoto H, Taguchi T, Iwamoto Y, Oda Y.

Hum Pathol. 2015 Feb;46(2):225-30. doi: 10.1016/j.humpath.2014.10.010. Epub 2014 Nov 4.

PMID:
25479928
6.

Malignant Ossifying Fibromyxoid Tumors: a report of two rare cases displaying retained INI1/SMARCB1 expression.

Rekhi B, Thorat S, Parikh G, Jambhekar NA.

Indian J Pathol Microbiol. 2014 Oct-Dec;57(4):652-3. doi: 10.4103/0377-4929.142717. No abstract available.

7.

The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.

Agaimy A.

Adv Anat Pathol. 2014 Nov;21(6):394-410. doi: 10.1097/PAP.0000000000000038. Review.

PMID:
25299309
8.

ALK inhibition for the treatment of refractory epithelioid inflammatory myofibroblastic sarcoma.

Fujiya M, Kohgo Y.

Intern Med. 2014;53(19):2177-8. No abstract available.

9.

[Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].

Li L, Xia Q, Rao Q, Liu B, Wu B, Shi S, Yu B, Zhang R, Lu Z, Zhou X.

Zhonghua Bing Li Xue Za Zhi. 2014 Jun;43(6):389-93. Chinese.

PMID:
25208989
10.

Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis.

Li L, Fan XS, Xia QY, Rao Q, Liu B, Yu B, Shi QL, Lu ZF, Zhou XJ.

Hum Pathol. 2014 Nov;45(11):2247-54. doi: 10.1016/j.humpath.2014.06.027. Epub 2014 Aug 5.

PMID:
25200863
11.

Bone and Soft Tissue Pathology: SC02-3 UNUSUAL SOFT TISSUE TUMORS.

Oda Y.

Pathology. 2014 Oct;46 Suppl 2:S5-6. doi: 10.1097/01.PAT.0000454062.08278.fc.

PMID:
25188186
12.

Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma.

Imura Y, Yasui H, Outani H, Wakamatsu T, Hamada K, Nakai T, Yamada S, Myoui A, Araki N, Ueda T, Itoh K, Yoshikawa H, Naka N.

Mol Cancer. 2014 Aug 7;13:185. doi: 10.1186/1476-4598-13-185.

13.

Orbital Epithelioid Sarcoma: A Case Report.

Jurdy LL, Blank LE, Bras J, Saeed P.

Ophthal Plast Reconstr Surg. 2014 Jul 28. [Epub ahead of print]

PMID:
25025387
14.

Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.

Le Loarer F, Zhang L, Fletcher CD, Ribeiro A, Singer S, Italiano A, Neuville A, Houlier A, Chibon F, Coindre JM, Antonescu CR.

Genes Chromosomes Cancer. 2014 Jun;53(6):475-86. doi: 10.1002/gcc.22159. Epub 2014 Mar 3.

15.

Immunoreactivity for Ca 125 and INI 1 loss of expression are useful markers in the diagnosis of vulvar proximal-type epithelioid sarcomas: report of two cases.

Cossu A, Paliogiannis P, Capobianco G, Sini MC, Dessole M, Dessole S, Palmieri G.

Eur J Gynaecol Oncol. 2013;34(5):469-72.

PMID:
24475586
16.

Rhabdoid glioblastoma is distinguishable from classical glioblastoma by cytogenetics and molecular genetics.

Byeon SJ, Cho HJ, Baek HW, Park CK, Choi SH, Kim SH, Kim HK, Park SH.

Hum Pathol. 2014 Mar;45(3):611-20. doi: 10.1016/j.humpath.2013.08.024. Epub 2013 Nov 7.

PMID:
24457079
17.

Selected topics in the pathology of epithelioid soft tissue tumors.

Folpe AL.

Mod Pathol. 2014 Jan;27 Suppl 1:S64-79. doi: 10.1038/modpathol.2013.175. Review.

18.

SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels.

Papp G, Krausz T, Stricker TP, Szendrői M, Sápi Z.

Genes Chromosomes Cancer. 2014 Feb;53(2):168-76. doi: 10.1002/gcc.22128. Epub 2013 Nov 5.

PMID:
24327545
19.

Proximal-type Epithelioid Sarcoma of the Head and Neck (HN): A Study with Immunohistochemical and Molecular Analysis of SMARCB1.

Frank R, Sadri N, Bhatti T, Biegel JA, Livolsi VA, Zhang PJ.

J Clin Exp Oncol. 2013;2(2). pii: 1000106.

20.

Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.

Kohashi K, Yamamoto H, Kumagai R, Yamada Y, Hotokebuchi Y, Taguchi T, Iwamoto Y, Oda Y.

Mod Pathol. 2014 Jun;27(6):832-9. doi: 10.1038/modpathol.2013.213. Epub 2013 Nov 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk